News

AT&T (NYSE: T) is a good dividend stock thanks to its high yield. At 5.9%, it's more than four times the S&P 500 average of 1.4%. For income investors, it can make an ideal investment for the long

Industry insiders often have perspectives that are invaluable for investors to learn. In that vein, AstraZeneca's (NASDAQ: AZN) CEO, Pascal Soriot, recently made some interesting remarks during the

Shares of Eli Lilly (NYSE: LLY) notched a 3.5% gain on Thursday, Aug. 1, after the company reported positive clinical trial results for its increasingly successful weight management treatment. It

What are the best stocks? Usually, the ones that have clear paths to success.

Three Motley Fool contributors have identified what they believe are unstoppable stocks to buy in August. And they all

Regeneron Pharmaceuticals (NASDAQ: REGN) stock is trading above the $1,000 mark. It's at a high enough threshold that the company could decide to split its stock. That would lower the share price

There are plenty of excellent reasons to invest in dividend stocks, including the fact that only rock-solid companies can afford to sustain payout increases for a long time. When you put your money

Few healthcare companies are more famous than Johnson & Johnson (NYSE: JNJ). The pharmaceutical giant earned its stature in the industry thanks to its incredible innovative abilities and a business

Five years ago, Novavax (NASDAQ: NVAX) was a little-known clinical-stage biotech whose leading pipeline candidate was an influenza vaccine. Then came the pandemic. The company quickly grew in

Eli Lilly (NYSE: LLY) stock has soared by double digits over the past year -- and for good reason. The pharma giant sells two of the most sought-after drugs today, weight loss treatments Mounjaro

The stock market had a terrible end to the week, and very few companies were spared from the carnage. Three that were up are in the telecom industry and probably aren't on your list of top stocks

In this video, I will explain why semiconductor stocks like Nvidia (NASDAQ: NVDA), Intel, Arm Holdings, and Advanced Micro Devices all crashed on Thursday and talk about whether this presents a

The biotech Amgen (NASDAQ: AMGN) isn't exactly known as a growth stock. Over the past few years, the company's organic revenue hasn't been increasing at a particularly impressive rate. The drugmaker

Vertex Pharmaceuticals (NASDAQ: VRTX) has churned out nice profits quarter after quarter for years. The big biopharmaceutical company's cystic fibrosis (CF) franchise made it easy.

However, Vertex

Johnson & Johnson (NYSE: JNJ) is one of the top healthcare companies in the world. Last year, it spun off its consumer health business to focus on growing other parts of its operations, which

Pfizer (NYSE: PFE) is one of the most successful pharmaceutical companies ever. In 2022, it brought in more than $100 billion in revenue -- a record for itself and for the entire industry. Of

Image source: The Motley Fool.

Vertex Pharmaceuticals (NASDAQ: VRTX)Q2 2024 Earnings CallAug 01, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Volatility continued for Nvidia (NASDAQ: NVDA) stock in Thursday's trading. The artificial intelligence (AI) leader's share ended the daily session down 6.7%, according to data from S&P Global

Image source: The Motley Fool.

Biogen (NASDAQ: BIIB)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Great companies can deliver meaningful portfolio growth in a wide range of economic and market environments. From established companies to emerging businesses, the types of stocks you favor will

Pfizer (NYSE: PFE) has been a nightmare for many investors in recent years. At one point earlier this year, the big pharma stock was nearly 60% below its peak set in late 2021.

However, the

The anti-obesity drug market could be worth a staggering $100 billion, according to some analysts. That's a huge growth opportunity, and it's a reason why many top drugmakers in the world are

Just a couple of years ago, Pfizer's (NYSE: PFE) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and even

Shares of data center infrastructure company Vertiv Holdings (NYSE: VRT), as well as nuclear power-oriented companies Constellation Energy (NASDAQ: CEG) and NuScale Power (NYSE: SMR) were rallying

Image source: The Motley Fool.

Amarin Plc (NASDAQ: AMRN)Q2 2024 Earnings CallJul 31, 2024, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com